Nifty
Sensex
:
:
24078.30
76909.68
-76.60 (-0.32%)
-325.78 (-0.42%)

Pharmaceuticals & Drugs - API

Rating :
71/99

BSE: 524164 | NSE: IOLCP

156.92
19-Aug-2026
  • Open
  • High
  • Low
  • Previous Close
  •  159.52
  •  159.98
  •  155.06
  •  159.19
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  1216026
  •  191225797.19
  •  179.6
  •  67.19

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 4,608.38
  • 27.41
  • 2
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 4,542.02
  • 0.13%
  • 2.47

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 62.28%
  • 2.44%
  • 26.94%
  • FII
  • DII
  • Others
  • 4.87%
  • 0.02%
  • 3.45%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 12.56
  • 1.21
  • 2.83

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 10.16
  • 0.81
  • 3.13

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 40.27
  • -3.87
  • 0.79

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 18.74
  • 18.74
  • 20.31

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 1.54
  • 1.54
  • 1.56

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 9.60
  • 9.60
  • 10.14

Earnings Forecasts:

(Updated: 15-08-2026)
Description
2026
2027
2028
2029
Adj EPS
64
11
35.76
4.4
P/E Ratio
2.45
14.27
4.39
35.66
Revenue
22.5
18.53
-
2303.5
EBITDA
2648.5
2999.3
-
240.9
Net Income
339
398.9
-
129.6
ROA
178.7
217.7
-
7.73
P/B Ratio
-40.76
-32.22
-
2.58
ROE
2.28
2.12
-
7.6
FCFF
10.5
11
-
93.44
FCFF Yield
302.09
182.06
1713.31
2.15
Net Debt
6.95
4.19
39.43
-1.88
BVPS
-3.85
-4.87
-
60.91

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Jun 26
Jun 25
Var%
Mar 26
Mar 25
Var%
Dec 25
Dec 24
Var%
Sep 25
Sep 24
Var%
Net Sales
756.26
551.69
37.08%
619.45
527.78
17.37%
580.39
523.30
10.91%
567.53
525.75
7.95%
Expenses
652.77
489.55
33.34%
526.98
465.03
13.32%
523.11
476.43
9.80%
510.45
484.18
5.43%
EBITDA
103.49
62.14
66.54%
92.47
62.75
47.36%
57.28
46.87
22.21%
57.08
41.57
37.31%
EBIDTM
13.68%
11.26%
14.93%
11.89%
9.87%
8.96%
10.06%
7.91%
Other Income
8.18
7.37
10.99%
1.84
4.53
-59.38%
5.29
4.07
29.98%
6.88
6.43
7.00%
Interest
3.64
4.23
-13.95%
3.21
4.03
-20.35%
3.63
4.46
-18.61%
3.48
4.12
-15.53%
Depreciation
21.34
19.77
7.94%
20.29
18.55
9.38%
20.18
18.68
8.03%
19.99
17.94
11.43%
PBT
86.69
45.51
90.49%
70.81
44.70
58.41%
27.55
27.80
-0.90%
40.49
25.94
56.09%
Tax
22.29
11.58
92.49%
17.65
13.28
32.91%
6.97
7.27
-4.13%
10.52
6.79
54.93%
PAT
64.40
33.93
89.80%
53.16
31.42
69.19%
20.58
20.53
0.24%
29.97
19.15
56.50%
PATM
8.52%
6.15%
8.58%
5.95%
3.55%
3.92%
5.28%
3.64%
EPS
2.19
1.16
88.79%
1.81
1.07
69.16%
0.70
0.70
0.00%
1.02
0.65
56.92%

Annual Results

Standalone Figures in Rs. Crores /

Consolidated
Description
TTM
Mar 26
Mar 25
Mar 24
Mar 23
Mar 22
Net Sales
2,523.63
2,319.06
2,079.21
2,132.79
2,217.11
2,184.02
Net Sales Growth
18.56%
11.54%
-2.51%
-3.80%
1.52%
 
Cost Of Goods Sold
1,600.85
1,487.10
1,391.85
1,396.95
1,547.09
1,570.51
Gross Profit
922.78
831.96
687.36
735.84
670.02
613.51
GP Margin
36.57%
35.87%
33.06%
34.50%
30.22%
28.09%
Total Expenditure
2,213.31
2,050.10
1,876.91
1,902.20
1,991.44
1,925.73
Power & Fuel Cost
-
154.93
114.93
149.05
131.98
78.18
% Of Sales
-
6.68%
5.53%
6.99%
5.95%
3.58%
Employee Cost
-
248.26
216.57
201.02
168.21
141.30
% Of Sales
-
10.71%
10.42%
9.43%
7.59%
6.47%
Manufacturing Exp.
-
58.85
47.39
47.67
43.07
36.86
% Of Sales
-
2.54%
2.28%
2.24%
1.94%
1.69%
General & Admin Exp.
-
6.16
8.10
9.01
6.54
5.12
% Of Sales
-
0.27%
0.39%
0.42%
0.29%
0.23%
Selling & Distn. Exp.
-
54.80
62.21
51.25
61.85
66.84
% Of Sales
-
2.36%
2.99%
2.40%
2.79%
3.06%
Miscellaneous Exp.
-
40.00
35.86
47.25
32.70
26.92
% Of Sales
-
1.72%
1.72%
2.22%
1.47%
1.23%
EBITDA
310.32
268.96
202.30
230.59
225.67
258.29
EBITDA Margin
12.30%
11.60%
9.73%
10.81%
10.18%
11.83%
Other Income
22.19
21.38
22.41
30.07
25.61
32.04
Interest
13.96
14.55
14.76
16.10
16.47
8.29
Depreciation
81.80
80.23
71.99
62.91
46.16
43.26
PBT
225.54
195.56
137.96
181.65
188.65
238.78
Tax
57.43
46.72
36.89
47.22
49.51
57.18
Tax Rate
25.46%
25.34%
26.74%
26.00%
26.24%
25.43%
PAT
168.11
137.64
101.07
134.43
139.14
167.67
PAT before Minority Interest
168.11
137.64
101.07
134.43
139.14
167.67
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
PAT Margin
6.66%
5.94%
4.86%
6.30%
6.28%
7.68%
PAT Growth
60.06%
36.18%
-24.82%
-3.39%
-17.02%
 
EPS
5.73
4.69
3.44
4.58
4.74
5.71

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 26
Mar 25
Mar 24
Mar 23
Mar 22
Shareholder's Funds
1,798.55
1,687.66
1,611.51
1,507.72
1,392.28
Share Capital
58.71
58.71
58.71
58.71
58.71
Total Reserves
1,739.84
1,628.95
1,552.80
1,449.01
1,333.57
Non-Current Liabilities
98.22
84.50
72.89
58.15
56.62
Secured Loans
0.00
0.00
0.00
0.00
0.00
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
Long Term Provisions
10.96
6.69
6.71
1.65
3.01
Current Liabilities
733.49
638.58
597.10
502.52
575.29
Trade Payables
482.56
427.56
469.18
314.22
409.29
Other Current Liabilities
69.85
63.34
54.67
54.28
54.02
Short Term Borrowings
132.00
117.04
32.76
79.63
42.75
Short Term Provisions
49.08
30.64
40.49
54.39
69.23
Total Liabilities
2,630.26
2,410.74
2,281.50
2,068.39
2,024.19
Net Block
1,181.57
1,170.71
933.13
751.81
560.64
Gross Block
1,632.08
1,544.27
1,235.97
995.24
761.99
Accumulated Depreciation
450.51
373.56
302.84
243.43
201.35
Non Current Assets
1,359.32
1,230.73
1,124.63
1,101.74
881.48
Capital Work in Progress
95.54
21.93
100.87
89.64
105.20
Non Current Investment
17.41
17.41
17.41
17.41
0.00
Long Term Loans & Adv.
19.74
12.15
23.62
9.52
10.77
Other Non Current Assets
45.06
8.53
49.60
233.36
204.87
Current Assets
1,270.94
1,180.01
1,156.87
966.65
1,142.71
Current Investments
3.51
3.30
2.88
2.56
2.37
Inventories
371.07
360.62
424.84
325.52
409.89
Sundry Debtors
603.13
513.69
471.23
505.28
469.80
Cash & Bank
198.36
208.15
142.89
21.83
139.99
Other Current Assets
94.87
26.92
24.91
29.86
120.66
Short Term Loans & Adv.
64.77
67.33
90.12
81.60
89.67
Net Current Assets
537.45
541.43
559.77
464.13
567.42
Total Assets
2,630.26
2,410.74
2,281.50
2,068.39
2,024.19

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 26
Mar 25
Mar 24
Mar 23
Mar 22
Cash From Operating Activity
214.32
178.62
289.78
122.27
93.05
PBT
184.36
137.96
181.65
188.65
224.85
Adjustment
85.04
79.85
59.82
44.41
33.12
Changes in Working Capital
-17.22
-20.87
90.33
-63.69
-102.34
Cash after chg. in Working capital
252.18
196.94
331.80
169.37
155.63
Interest Paid
0.00
0.00
0.00
0.00
0.00
Tax Paid
-37.86
-18.32
-42.02
-47.10
-62.58
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-198.11
-154.18
-190.98
-120.00
-120.52
Net Fixed Assets
-161.42
-229.36
-251.96
-217.16
Net Investments
-0.11
-0.42
-0.32
-17.80
Others
-36.58
75.60
61.30
114.96
Cash from Financing Activity
-29.03
46.04
-92.50
-4.11
-1.64
Net Cash Inflow / Outflow
-12.82
70.48
6.30
-1.84
-29.11
Opening Cash & Equivalents
78.17
7.69
1.39
3.23
32.34
Closing Cash & Equivalent
65.35
78.17
7.69
1.39
3.23

Financial Ratios

Standalone /

Consolidated
Description
Mar 26
Mar 25
Mar 24
Mar 23
Mar 22
Book Value (Rs.)
61.27
57.49
54.90
256.81
237.15
ROA
5.46%
4.31%
6.18%
6.80%
8.28%
ROE
7.90%
6.13%
8.62%
9.60%
12.04%
ROCE
10.65%
8.86%
12.24%
13.57%
16.25%
Fixed Asset Turnover
1.46
1.50
1.91
2.52
2.87
Receivable days
87.89
86.45
83.56
80.26
78.51
Inventory Days
57.58
68.94
64.21
60.53
68.50
Payable days
111.69
117.58
102.34
85.35
95.12
Cash Conversion Cycle
33.78
37.81
45.42
55.45
51.89
Total Debt/Equity
0.07
0.07
0.02
0.05
0.03
Interest Cover
13.67
10.35
12.28
12.45
28.12

Top Investors:

News Update:


  • IOL Chem & Pharma - Quarterly Results
    11th Aug 2026, 00:00 AM

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.